Patent ID: 6890955

Claim:
A method of treating diabetes, obesity or intestinal motility disorders in an animal comprising administration of a composition comprising at least one compound of general formula I below: in which: R 1 , a substituent in the 2-, 3- or 4-position of the phenyl group, is a hydrogen atom, a halogen atom or one of the following groups: hydroxyl; C 1 -C 10 lower alkyl selected in particular from methyl, ethyl, propyl, isopropyl, butyl and tert-butyl groups; C 1 -C 10 -alkoxy; benzyloxy; nitro; cyano; trifluoromethyl; or amino optionally substituted (monosubstituted or disubstituted) by 1 or 2 lower alkyl radicals as defined above; R 2 is one of the following groups: —CH 2 —, —CH 2 —CH 2 —, —CH(CH 3 )—CH 2 —, —C(CH 3 )═CH—, —C(CH 3 ) 2 —CH 2 —, or a bond; and Q is an optionally bridged, cyclic hydrocarbon system which consists of a cyclo-alkane comprising 1, 2 or 3 rings optionally containing substituents selected from methyl, ethyl, isopropyl, propyl, butyl and tert-butyl groups, the main ring containing 5 or 6 members; in the pure state or in the form of salts with pharmaceutically acceptable acids or bases, and at least one pharmaceutically acceptable vehicle; said compound being administered at a dose ranging from 0.1 to 100 mg/kg of live weight.